Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05671874
Other study ID # H00024195
Secondary ID R21NR020231
Status Recruiting
Phase N/A
First received
Last updated
Start date March 28, 2023
Est. completion date September 30, 2025

Study information

Verified date April 2024
Source University of Massachusetts, Worcester
Contact Susanne Muehlschlegel, MD, MPH
Phone (617)866-8289
Email susanne.muehlschlegel@umassmed.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal is to pilot test a highly accessible, web-based, pragmatic, scalable intervention to overcome ongoing problems with high stakes decision-making by surrogate decision-makers of patients in ICUs with severe acute brain injury (SABI), including those with moderate-severe traumatic brain injury, large hemispheric acute ischemic stroke and intracerebral hemorrhage.


Description:

Every 30 seconds an adult in the U.S. suffers a severe acute brain injury (SABI) from traumatic brain injury or large ischemic or hemorrhagic stroke, resulting in 200,000 deaths and >900,000 survivors living with disability annually. Every day, surrogate decision-makers face the difficult "goals of care" decision in intensive care units (ICUs) to continue or withdraw life support while considering the patient's long-term prognosis. In this study, we will pilot test a pragmatic, scalable intervention to overcome ongoing problems with high stakes decision-making by surrogates of patients with SABI in ICUs. These problems are an important target for intervention, because they contribute to 3 major clinical and public health issues: 1) family members struggle in the role of surrogate, leading to lasting symptoms of psychological distress; 2) clinicians are poorly trained in communicating prognosis after SABI, often doing so with variability and bias, inadequately preparing families for their decisions; 3) patients often receive burdensome treatments that they would not choose. Decision aids improve the quality of patients' decisions based on a large evidence-base, but no empirically validated tools currently exist for surrogate decision-making in SABI patients at high risk for death or disability. This is problematic because surrogates of SABI patients are unprepared for the difficult decisions about the use of life support and patients' potential long-term disability, which hinge on both medical information and the patient's values and preferences. We have developed and refined a tailored digital, web-based decision aid (DA) for families of critically ill SABI patients, conceptually grounded in the Ottawa Decision Support Framework, to enhance, not replace, clinician-family communication. We will leverage a digital platform, which is portable and shareable among family members when geographically distant or not allowed to visit the ICU (as during the COVID-19 pandemic) and allows integration of videos to reach lower-literacy groups. This innovative tool challenges the existing paradigm for decision-making in SABI patients. This pilot study among 50 surrogates of SABI patients and their clinicians will assess the feasibility of deploying the web-based tool as well as to explore the tools impact on measures of communication and decision-quality.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date September 30, 2025
Est. primary completion date June 30, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria for surrogates and patients: - surrogate is age 18 years or older, no upper age limit; - documented surrogate decision-maker (official health care proxy, or legal next of kin) of a critically ill severe acute brain injury (SABI) patient = 3 days after admission; - patient is age 18 years or older, no upper age limit; - patient has SABI; defined as either traumatic brain injury, spontaneous primary intracerebral hemorrhage (not due to tumor or vascular malformation), or hemispheric acute ischemic stroke; - patient is"critically ill" defined as either intubated on a mechanical ventilator, or unable to swallow without a feeding tube (even if not intubated/ventilated); - patient is judged by the attending physician to have =40% risk of death or long-term functional impairment, elicited by asking the attending physician, "does this patient have at least a 40% chance of in-hospital mortality or long-term functional impairment?", defined as needing assistance with at least 1 activity of daily living (ADL). - patient has undergone initial stabilization but remains critically ill; - surrogate will participate in clinician-family goals of care meeting, either in person or via video- or telephone-conference. - surrogate must be English speaking and literate Exclusion Criteria for surrogates and patients: - devastating patients with severe SABI who die early (within the first 3 days after admission); - surrogate decision-maker is non-English speaking; - surrogate decision-maker is illiterate. Inclusion criteria for clinicians: - clinical treating attending, or physician trainee (fellow, resident), or licensed affiliated practitioner who will lead the clinician-family meeting when goals-of-care are discussed; - clinician may decline participation in the outcome measures but cannot restrict the surrogate decision-maker in study participation. Exclusion criteria for clinicians: - unwillingness to comply with study protocol.

Study Design


Intervention

Behavioral:
Web/mobile/tablet-based digital decision aid + communication (DA+C) tool
The web/mobile/tablet-based digital DA+C toll is designed to enhance communication and shared decision making between clinicians and surrogates of critically ill severe acute brain injury (SABI) with four goals: to 1) prepare families for their surrogate role and discussions with clinicians; 2) provide balanced information to families on prognosis and all available treatment options; 3) provide tailored information about the patient and family to clinicians in advance of family meetings; and 4) serve as a communication guide for clinicians in the clinician-family meeting to facilitate shared decision-making.

Locations

Country Name City State
United States Johns Hopkins Bayview Medical Center Baltimore Maryland
United States Johns Hopkins Hospital Baltimore Maryland
United States UMass Memorial Hospital Worcester Massachusetts

Sponsors (5)

Lead Sponsor Collaborator
University of Massachusetts, Worcester Johns Hopkins University, National Institute of Nursing Research (NINR), National Institutes of Health (NIH), Worcester Polytechnic Institute

Country where clinical trial is conducted

United States, 

References & Publications (5)

Goostrey K, Muehlschlegel S. Prognostication and shared decision making in neurocritical care. BMJ. 2022 Apr 7;377:e060154. doi: 10.1136/bmj-2021-060154. — View Citation

Goostrey KJ, Lee C, Jones K, Quinn T, Moskowitz J, Pach JJ, Knies AK, Shutter L, Goldberg R, Mazor KM, Hwang DY, Muehlschlegel S. Adapting a Traumatic Brain Injury Goals-of-Care Decision Aid for Critically Ill Patients to Intracerebral Hemorrhage and Hemispheric Acute Ischemic Stroke. Crit Care Explor. 2021 Mar 9;3(3):e0357. doi: 10.1097/CCE.0000000000000357. eCollection 2021 Mar. — View Citation

Muehlschlegel S, Goostrey K, Flahive J, Zhang Q, Pach JJ, Hwang DY. Pilot Randomized Clinical Trial of a Goals-of-Care Decision Aid for Surrogates of Patients With Severe Acute Brain Injury. Neurology. 2022 Oct 3;99(14):e1446-e1455. doi: 10.1212/WNL.0000000000200937. — View Citation

Muehlschlegel S, Hwang DY, Flahive J, Quinn T, Lee C, Moskowitz J, Goostrey K, Jones K, Pach JJ, Knies AK, Shutter L, Goldberg R, Mazor KM. Goals-of-care decision aid for critically ill patients with TBI: Development and feasibility testing. Neurology. 2020 Jul 14;95(2):e179-e193. doi: 10.1212/WNL.0000000000009770. Epub 2020 Jun 17. — View Citation

Muehlschlegel S, Perman SM, Elmer J, Haggins A, Teixeira Bailey ND, Huang J, Jansky L, Kirchner J, Kasperek-Wynn R, Lipman PD, Yeatts SD, Fetters MD, Dickert NW, Silbergleit R. The Experiences and Needs of Families of Comatose Patients After Cardiac Arrest and Severe Neurotrauma: The Perspectives of National Key Stakeholders During a National Institutes of Health-Funded Workshop. Crit Care Explor. 2022 Mar 4;4(3):e0648. doi: 10.1097/CCE.0000000000000648. eCollection 2022 Mar. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Participants' ratings of what they liked and disliked about the DA+C tool (Intervention surrogates only) Measured by two open ended questions from the Acceptability Scale. Until right before the scheduled clinician-family meeting, an average of 10-14 days after admission
Other Surrogates' clarity about patient values & preferences We will apply the 3-item Values Clarity Subscale of the Decisional Conflict Scale. After the scheduled clinician-family meeting, an average of 10-14 days after admission
Other Surrogates' ratings of the degree of shared decision-making We will apply six questions from Quality of Communication Scale pertaining to shared decision-making. After the scheduled clinician-family meeting, an average of 10-14 days after admission
Other Caregiver Burden Measured with the 5-item short form of the Caregiver Burden Scale. Three-months post SABI
Other Decision Regret Measured using the Decision Regret Scale. Three-months post SABI
Other Goals-of-care decision Final goals-of-care decision by surrogates (survival vs. withdrawal of life sustaining treatments) Hospital discharge up until 3-months post SABI
Other Mortality Patient death Hospital discharge up until 3-months post SABI
Other Functional status We will measure basic activities of daily living with the Glasgow Outcome Scale Extended (GOSE; range 1-8) and the modified Rankin Scale (range 0-6) 3-months post SABI
Other Patient-perceived Patient- Centeredness of Care To assess patient centeredness of care adapted for use by surrogates 3-months post SABI
Primary Feasibility of tool use by surrogate decision-makers Data tracking analytics built into the tool will be employed to determine the extent to which the tools is used as per protocol. Duration of ICU stay, an expected average of 4 weeks
Primary Feasibility of enrolling surrogates in a stepped-wedge (before/after) clinical trial in a neurocritical care setting Measured by meeting target enrollment. Through study completion, estimated 18 months past primary start date
Primary Feasibility of retaining surrogates in a neurocritical care setting The number of subjects that complete the long-term follow-up. Three-months post SABI
Secondary Participants' ratings of usability of the tool (Intervention surrogates only) Usability of the tool as measured with the System Usability Scale. Duration of ICU stay, an expected average of 4 weeks
Secondary Participants' ratings of perceived effectiveness of the tool in preparing them for decision-making (Intervention surrogates only) Perceived Effectiveness will be measured with an 11-item perceived effectiveness questionnaire using a 5-point Likert scale. Duration of ICU stay, an expected average of 4 weeks
Secondary Fidelity to intervention protocol Fidelity to the intervention protocol will be measured using self-checklists by clinicians and review of a random selection of 30% of the audio-recorded clinician-family meetings Through study completion, estimated 18 months past primary start date
See also
  Status Clinical Trial Phase
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT05503316 - The Roll of Balance Confidence in Gait Rehabilitation in Persons With a Lesion of the Central Nervous System N/A
Completed NCT04356963 - Adjunct VR Pain Management in Acute Brain Injury N/A
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Terminated NCT03698747 - Myelin Imaging in Concussed High School Football Players
Recruiting NCT05130658 - Study to Improve Ambulation in Individuals With TBI Using Virtual Reality -Based Treadmill Training N/A
Recruiting NCT04560946 - Personalized, Augmented Cognitive Training (PACT) for Service Members and Veterans With a History of TBI N/A
Completed NCT05160194 - Gaining Real-Life Skills Over the Web N/A
Recruiting NCT02059941 - Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP) Monitoring Guidelines N/A
Recruiting NCT03940443 - Differences in Mortality and Morbidity in Patients Suffering a Time-critical Condition Between GEMS and HEMS
Recruiting NCT03937947 - Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
Completed NCT04465019 - Exoskeleton Rehabilitation on TBI
Recruiting NCT04530955 - Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS) N/A
Recruiting NCT03899532 - Remote Ischemic Conditioning in Traumatic Brain Injury N/A
Suspended NCT04244058 - Changes in Glutamatergic Neurotransmission of Severe TBI Patients Early Phase 1
Completed NCT03307070 - Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury N/A
Recruiting NCT04274777 - The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders
Withdrawn NCT05062148 - Fundamental and Applied Concussion Recovery Modality Research and Development: Applications for the Enhanced Recovery N/A
Withdrawn NCT04199130 - Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI N/A
Withdrawn NCT03626727 - Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia Early Phase 1